GLP-1 medications, while effective for weight loss and improving cardiovascular health, carry a hidden risk of significant muscle and bone density loss. This can increase fracture risk, particularly in older adults and menopausal women who are already vulnerable to bone density decline. Experts recommend that patients on GLP-1s work closely with their doctors to develop comprehensive treatment plans that include strength training, proper nutrition with adequate calcium, vitamin D, and magnesium, to mitigate these secondary effects and preserve long-term musculoskeletal health. AI
RANK_REASON Article discusses risks and management strategies for an existing class of drugs, not a new release or research breakthrough.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
